ARYNTA

LISDEXAMFETAMINE DIMESYLATE ORAL · Azurity Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARYNTA, covering 2025-06-16 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: ARYNTA — Supplemental Application (Azurity Pharmaceuticals, Inc.)